Handbook of Neurodegenerative Disorders: Mechanism, Diagnostic and Therapeutic Advances provides a comprehensive review on the current biomedical studies aimed at identifying the underlying causes of neurodegeneration. This book reviews the most recent developments in molecular and cellular processes altered during neurodegeneration. Divided into four parts, the first covers the mechanism of cell death in neurodegeneration. The second section reviews the recent progress in gene and gene products in neurodegeneration, including Huntington's disease, Parkinson's disease, Friedreich' s ataxia,…mehr
Handbook of Neurodegenerative Disorders: Mechanism, Diagnostic and Therapeutic Advances provides a comprehensive review on the current biomedical studies aimed at identifying the underlying causes of neurodegeneration. This book reviews the most recent developments in molecular and cellular processes altered during neurodegeneration. Divided into four parts, the first covers the mechanism of cell death in neurodegeneration. The second section reviews the recent progress in gene and gene products in neurodegeneration, including Huntington's disease, Parkinson's disease, Friedreich' s ataxia, and spinal muscular atrophy. The final sections cover the current and future diagnostic techniques of neurodegenerative disorders along with therapeutic approaches.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Part-I: Mechanism of cell death in neurodegeneration 1. Pathways in AD 2. Shared signalling pathways in Alzheimer’s and metabolic disease 3. Abeta pathology in AD and its potential to seed and propagate 4. Single-cell approaches to identify shared and distinct signatures across neurodegenerative diseases 5. Modelling of neurodegenerative disease using brain organoids 6. The structural basis of protein assembly into amyloid filaments in neurodegenerative disease-Benjamin 7. Blood brain barrier in neurodegenerative disorders 8. Protein misfolding in neurodegeneration 9. Neuroinflammation and neurodegeneration 10. Gut-Brain Axis in neurodegeneration 11. Modelling Neural Circuits in Parkinson’s Disease 12. Neuropathology of Parkinsonism in Alzheimer’s Disease 13. Huntington Disease updates 14. Neuroinflammation in neurodegeneration Part-II: Gene and gene products in neurodegeneration 15. Big data and neurodegeneration disorders 16. Genomics and PD 17. RNA Binding Proteins and the Genesis of Neurodegenerative Diseases-Ahmed Moustafa, Egypt 18. Molecular Genetics of Huntington’s Disease 19. neuronopathic LSDs: opportunities and challenges 20. Nutrigenomics and PD 21. Genes and MS: updates 22. Genetic mapping and big data in ALS Part-III: Present and future diagnostic approaches of neurodegenerative disorders 23. Biomarkers in AD 24. Biomarkers of PD 25. HMGB complex in PD diagnosis 26. Psychological assessment of PD patients Part-IV: Present and future therapeutics of neurodegenerative disorders 27. Pharmacotherapy of neurodegenerative disorders: challenges and hopes 28. Advanced Drug Delivery Nanosystems: Perspectives and Regulatory Issues 29. Towards the Development of a Device to Improve the Gait of Patients Suffering from Parkinson’s Disease 30. Developing Antisense Therapies for Neurodegenerative Diseases 31. Advances in Gene Therapies for the CNS 32. Nutrition and PD 33. Stem cell therapy in NDG disorders
Part-I: Mechanism of cell death in neurodegeneration 1. Pathways in AD 2. Shared signalling pathways in Alzheimer’s and metabolic disease 3. Abeta pathology in AD and its potential to seed and propagate 4. Single-cell approaches to identify shared and distinct signatures across neurodegenerative diseases 5. Modelling of neurodegenerative disease using brain organoids 6. The structural basis of protein assembly into amyloid filaments in neurodegenerative disease-Benjamin 7. Blood brain barrier in neurodegenerative disorders 8. Protein misfolding in neurodegeneration 9. Neuroinflammation and neurodegeneration 10. Gut-Brain Axis in neurodegeneration 11. Modelling Neural Circuits in Parkinson’s Disease 12. Neuropathology of Parkinsonism in Alzheimer’s Disease 13. Huntington Disease updates 14. Neuroinflammation in neurodegeneration Part-II: Gene and gene products in neurodegeneration 15. Big data and neurodegeneration disorders 16. Genomics and PD 17. RNA Binding Proteins and the Genesis of Neurodegenerative Diseases-Ahmed Moustafa, Egypt 18. Molecular Genetics of Huntington’s Disease 19. neuronopathic LSDs: opportunities and challenges 20. Nutrigenomics and PD 21. Genes and MS: updates 22. Genetic mapping and big data in ALS Part-III: Present and future diagnostic approaches of neurodegenerative disorders 23. Biomarkers in AD 24. Biomarkers of PD 25. HMGB complex in PD diagnosis 26. Psychological assessment of PD patients Part-IV: Present and future therapeutics of neurodegenerative disorders 27. Pharmacotherapy of neurodegenerative disorders: challenges and hopes 28. Advanced Drug Delivery Nanosystems: Perspectives and Regulatory Issues 29. Towards the Development of a Device to Improve the Gait of Patients Suffering from Parkinson’s Disease 30. Developing Antisense Therapies for Neurodegenerative Diseases 31. Advances in Gene Therapies for the CNS 32. Nutrition and PD 33. Stem cell therapy in NDG disorders
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
